Hester Biosciences (HESTERBIO) | Stock Overview & Key Data
Hester Biosciences Performance Comparison
Stock Range
Today's Range
Low: ₹1,934.60
High: ₹2,155.70
on August 20, 2025
52 Week Range
Low: ₹1,242.95
High: ₹2,786.10
on March 28, 2025
on November 8, 2024
All-Time High: ₹3,379.00 on July 22, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR16.2B
EPS
43.93
P/E Ratio (TTM)
43.11
Forward P/E
N/A
P/B Ratio
5.13
PEG Ratio
0.33
Div. Yield
0.64%
ROE
8.41%
Beta
0.122
Debt to Equity
68.46
Financial Highlights
Profitability
Gross Margin
73.29%
Operating Margin
24.24%
Profit Margin
11.92%
Returns and Earnings
Return on Assets (TTM)
4.21%
Return on Equity (TTM)
8.41%
EBITDA
INR623.7M
Net Income (TTM)
INR375.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR370.76
Quarterly Revenue Growth (YoY)
3.50%
Quarterly Earnings Growth (YoY)
159.50%
Dividend Information
Last 12-Month Dividend
₹13.00
Current Dividend Yield
0.64%
3-Year Average Dividend Yield
0.37%
3-Year Average Annual Dividend
₹10.33
3-Year Total Dividends
₹31.00
Ex-Dividend Date
August 6, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Hester Biosciences HESTERBIO | 16.17B Small-cap | 0.04% | 2.49% | 5.59% | 21.29% | -18.59% | -21.38% | -8.50% | 30.96% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 0.27% | -3.88% | -5.99% | -2.98% | -13.93% | -8.40% | 84.81% | 192.69% |
| Divi's Laboratories DIVISLAB | 1.64T Large-cap | 1.99% | -9.10% | -7.61% | 2.44% | 0.11% | 25.20% | 69.46% | 85.76% |
| Sun Pharma Advanced SPARC | 45.51B Small-cap | 4.19% | -8.09% | -11.48% | 12.35% | -26.33% | -34.00% | -36.71% | -22.67% |
| Aarti Drugs AARTIDRUGS | 44.80B Small-cap | 0.27% | -9.96% | 2.11% | 28.03% | 7.74% | -12.97% | 12.03% | -33.03% |
| Sequent Scientific SEQUENT | 43.92B Small-cap | 1.51% | -5.78% | -0.25% | 17.84% | -4.22% | 5.62% | 52.82% | 30.86% |
Ownership & Short Interest
Insider Ownership
68.50%
Institutional Ownership
0.35%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
52K
Average 90-Day Volume
20K
Hester Biosciences Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Hester Biosciences would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is HESTERBIO's 52-week high and low?
- In the last 52 weeks, Hester Biosciences reached a high of ₹2,786.10 (on November 8, 2024) and a low of ₹1,242.95 (on March 28, 2025).
- What is the market cap and P/E ratio for HESTERBIO?
- Curious about Hester Biosciences's size and valuation? Its market capitalization stands at 16.17B. When it comes to valuation, the P/E ratio (trailing twelve months) is 43.11, and the forward P/E (looking ahead) is N/A.
- Does HESTERBIO pay dividends? If so, what's the yield?
- Yes, Hester Biosciences is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.64%, and the company has paid an average of ₹10.33 per share annually over the past 3 years.
- Who are Hester Biosciences's main competitors or similar companies to consider before investing?
When looking at Hester Biosciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -8.40% 84.81% Divi's Laboratories
DIVISLAB1.64T Healthcare Drug Manufacturers - Specialty & Generic 25.20% 69.46% Sun Pharma Advanced
SPARC45.51B Healthcare Drug Manufacturers - Specialty & Generic -34.00% -36.71% Aarti Drugs
AARTIDRUGS44.80B Healthcare Drug Manufacturers - Specialty & Generic -12.97% 12.03% Sequent Scientific
SEQUENT43.92B Healthcare Drug Manufacturers - Specialty & Generic 5.62% 52.82% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Hester Biosciences Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Hester Biosciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 8.41%, the Debt to Equity ratio from the most recent quarter is 68.46, and its Gross Profit Margin stands at 73.29%.
- What is the recent revenue and earnings growth for HESTERBIO?
- Looking at Hester Biosciences's growth, its revenue over the trailing twelve months (TTM) was INR3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 3.50%, and quarterly earnings saw a YoY growth of 159.50%.
- How much of HESTERBIO stock is held by insiders and institutions?
- Wondering who owns Hester Biosciences stock? Company insiders (like executives and directors) hold about 68.50% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.35%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.